Solid IO raised €800K in its first funding round to enhance cancer treatment with tumor-on-chip technology.
Amount Raised
€800,000
Round Type
Seed
HelsinkiBiotechnologyHealth CareMedicalTherapeuticsDescription
Solid IO, a medtech startup, closed its first funding round of €800,000 to develop a tumor-on-chip platform that accurately simulates patient-specific cancer responses. This innovative technology aims to improve patient outcomes in cancer treatment while reducing unnecessary side effects.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Solid IO that raised within 45 days of this round, from Fundz verified event records.
- Accure Therapeutics S.L raised $1.6M (Seed) on April 7, 2025.
- Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
- StimOxyGen raised $2M on March 11, 2025.
- Monument Therapeutics raised $1.1M (Seed) on February 25, 2025.
- Ceretas raised $1M (Seed) on February 21, 2025.
- MAIA Biotechnology raised $4.1M (Seed) on February 18, 2025.
Who to call at Solid IO, and when
A new round usually means Solid IO is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Solid IO raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Solid IO, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Solid IO. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Solid IO raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Solid IO raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.